Farah Anwar

Farah Anwar is the Head of Development Operations at Sana Biotechnology and serves as the Leader of Inclusion, Diversity and Equity.

Farah has been chairing Sana’s diversity committee, Voices at Sana since its inception in 2018. She was most recently Vice President, Clinical Operations at Juno Therapeutics. Previously she was Executive Director, Global Commercial Planning at Ultragenyx Pharmaceuticals where she helped build out the Global Commercial organization and served as Chief of Staff to the Chief Commercial Officer.

Farah served in various roles in strategic operations and study management at Genentech including Head of Study Management for Immunology, Infectious Disease, Ophthalmology and Neuroscience. Earlier in her career, Farah was at MedImmune where she started in Medical Affairs then worked as a Clinical Program Lead in Development working on infectious disease programs.

Farah holds a BS in Physical Therapy from the University of Maryland and a MS in Clinical Research Administration from the George Washington University.